Integral Derivatives’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.02M Buy
+8,736
New +$1M 0.02% 235
2017
Q4
Sell
-16,406
Closed -$1.67M 1148
2017
Q3
$1.53M Sell
16,406
-1,526
-9% -$140K 0.03% 376
2017
Q2
$1.55M Sell
17,932
-9,730
-35% -$847K 0.03% 366
2017
Q1
$2.28M Buy
+27,662
New +$2.21M 0.04% 277
2016
Q4
Sell
-23,184
Closed -$1.68M 1144
2016
Q3
$1.65M Buy
23,184
+18,787
+427% +$1.47M 0.03% 313
2016
Q2
$349K Sell
4,397
-5,742
-57% -$451K 0.01% 698
2016
Q1
$749K Buy
10,139
+7,044
+228% +$485K 0.02% 428
2015
Q4
$243K Sell
3,095
-11,463
-79% -$895K 0.01% 876
2015
Q3
$1.01M Buy
+14,558
New +$1.03M 0.03% 492

Other funds holding CRM

Integral Derivatives's CRM Position: Q1 2018 in Review

Integral Derivatives opened a new position in Salesforce (CRM) in Q1 2018: 8,736 shares worth $1.02M. The stake represents 0.02% of the portfolio and ranks #235 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in CRM as recently as Q3 2017.

Integral Derivatives first reported a position in CRM in Q3 2015 and has held it in 9 quarters since. The position peaked at $2.28M in Q1 2017. 1,076 funds tracked by Wall St. Rank hold CRM as of Q1 2018.

  • Integral Derivatives held 8,736 shares of Salesforce worth $1.02M as of Q1 2018.
  • Salesforce was a new Integral Derivatives position in Q1 2018.
  • Salesforce made up 0.02% of Integral Derivatives's portfolio in Q1 2018, its #235 holding.
  • Integral Derivatives first reported a position in Salesforce in Q3 2015 and has held it in 9 quarters since.
  • Integral Derivatives's Salesforce position peaked at $2.28M in Q1 2017.
  • 1,076 funds tracked by Wall St. Rank held Salesforce as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.